Fraction of colorectal cancer cases that metastasize to the liver
| Value | 60 % |
|---|---|
| Organism | Human Homo sapiens |
| Reference | Geva R, Prenen H, Topal B, Aerts R, Vannoote J, Van Cutsem E. Biologic modulation of chemotherapy in patients with hepatic colorectal metastases: the role of anti-VEGF and anti-EGFR antibodies. J Surg Oncol. 2010 Dec 15 102(8):937-45. p.937 left column 3rd paragraphPubMed ID21165996 |
| Primary Source | Kemeny N. Presurgical chemotherapy in patients being considered for liver resection. Oncologist. 2007 Jul12(7):825-39.PubMed ID17673614 |
| Comments | Liver metastases are present in 15–25% of patients at diagnosis and develop in about 60% of patients during the course of the disease [Primary source]. |
| Entered by | Uri M |
| ID | 106160 |